Pending FTC approval of Merial acquisition, BI will sell Duramune, ULTRA, Fel-O-Vax and other lines.
Boehringer Ingelheim Vetmedica has agreed to sell its portfolio of U.S. canine, feline and rabies vaccines, as well as the manufacturing and R&D site, to Elanco Animal Health for a price of $885 million, according to a company release. This price includes the estimated cost of acquired inventory. The sale is conditioned on antitrust approval and the Boehringer Ingelheim/Sanofi asset swap that was signed in June 2016.
“This agreement is an important step toward a successful acquisition of Merial,” says Dr. Albrecht Kissel, president and CEO of Boehringer Ingelheim Vetmedica, in the release. “This was a highly complex decision from a business and from an emotional perspective. It was certainly not taken lightly particularly in view of the history and significant positive developments of this business over the past years.
“We are confident that, under Elanco's leadership, customers will continue to have access to these innovative vaccines and the portfolio will have strong support,” Kissel says.
The sale to Elanco is anticipated to close in early 2017 subject to approval from the Federal Trade Commission and other contingencies, the release states.
Vaccines included in the proposed sale:
Canine:
> Duramune
> Duramune Max 5/4L
> Duramune Max 5
> Duramune Max 5-Cvk/4L
> Duramune Max 5-Cvk
> Duramune Max Pv
> Duramune CV-K
> Duramune Max PC
> Duramune Adult 3
> LeptoVax 4
> LeptoVax 4/C
> Bronchi-Shield
> Bronchi-Shield ORAL
> Bronchi-Shield III
> Duramune Lyme
> Duramune Lyme
> Duramune Lyme +LeptoVax 4
> Duramune Lyme +Leptovax 4/C
> Duramune Lyme +Max 5/4L
> Duramune Lyme +Max5-CvK/4L
> Duramune Lyme +Max5-CvK
> ULTRA Duramune
> ULTRA Duramune DAP+4L
> ULTRA Duramune DAP
> ULTRA Duramune 4L
> ULTRA Duramune DAP+C4L
> ULTRA Duramune DAP+C
> ULTRA Duramune Lyme
Feline:
> Fel-O-Vax
> Fel-O-Vax Lv-K III + CaliciVax
> Fel-O-Vax Lv-K
> Fel-O-Vax Lv-K/FIV
> Fel-O-Vax IV+CaliciVax
> Fel-O-Vax PCT+CaliciVax
> Fel-O-Vax Lv-K IV+CaliciVax
> Fel-O-Vax FIV
> CaliciVax
> ULTRA Fel-O-Vax
> ULTRA Fel-O-Vax FVRCP+FeLV
> ULTRA Fel-O-Vax FVRCP
> ULTRA Fel-O-Vax FeLV
> ULTRA Fel-O-Vax Dual FCV
> ULTRA Hybrid FVRCP
> Fel-O-Guard
> Fel-O-Guard Plus 3
> Fel-O-Guard Plus 3+Lv-K
> Fel-O-Guard Plus 4
> Fel-O-Guard Plus 4 +Lv-K
Rabies:
> Rabvac
> Rabvac 3
> Rabvac 1
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More
dvm360 announces winners of the Veterinary Heroes program
Published: September 6th 2024 | Updated: November 5th 2024This year’s event is supported by corporate sponsor Schwarzman Animal Medical Center and category sponsors Blue Buffalo Natural, MedVet, Banfield Pet Hospital, Thrive Pet Healthcare and PRN Pharmacal.
Read More